statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement...

TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology

TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA...

TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

China Universal Asset Management Co. Ltd. raised its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 351.0% during the 4th quarter, according to its most recent...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Holdings Lifted by China Universal Asset Management Co. Ltd.

Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...

Dyadic Reports 2023 Full Year Results and Recent Company Progress

This is a signal that MRVI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Maravai LifeSciences Holdings (MRVI, $8.76) RSI Indicator left the overbought zone on March 22, 2024

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

Investors considering a purchase of Maravai LifeSciences Holdings Inc (MRVI) stock, but tentative about paying the going market price of 7.80/share, might benefit from considering selling puts...

Commit To Purchase Maravai LifeSciences Holdings At $5, Earn 15% Using Options

Maravai LifeSciences Holdings (MRVI, $7.72) RSI Indicator left the overbought zone on February 29, 2024

QRG Capital Management Inc. acquired a new stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI  Free Report) during the third quarter, according to its most recent filing with the SEC...

QRG Capital Management Inc. Buys New Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Watchers	942
52-Wk Low	$4.52
52-Wk High	$16.62

Volume	2.3M
52-Wk High	$16.62
52-Wk Low	$4.52

MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals